Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized trial of aspirin versus rivaroxaban after surgical bioprosthetic aortic valve replacement
2016-002291-27Phase 4Completed
- Sponsor
- Aalborg University Hospital
- Start
- Jun 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in aortic stenosis (AS), stroke, myocardial infarction (MI) and 1 more comparing Rivaroxaban arm with Aspirin arm (2 arms). Primary endpoint: Composite of all-cause mortality, stroke, and myocardial infarction. Started Jun 2016; status: completed.
02
Drugs
rivaroxabanaspirin
03
Conditions
aortic stenosis (AS)strokemyocardial infarction (MI)arterial thromboembolism
Beyond the preview
Go deeper on 2016-002291-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002291-27.